Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) CEO Jeremy Bender sold 7,873 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $16.08, for a total transaction of $126,597.84. Following the completion of the sale, the chief executive officer now […]
FY2027 EPS Estimates for Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Lowered by Analyst theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
FY2027 EPS Estimates for Day One Biopharmaceuticals, Inc. Cut by Wedbush (NASDAQ:DAWN) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Day One Biopharmaceuticals (NASDAQ:DAWN) Given Outperform Rating at Wedbush tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) CEO Sells $163,398.90 in Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report)’s share price was up 5.2% during mid-day trading on Monday . The company traded as high as $16.03 and last traded at $15.70. Approximately 267,345 shares traded hands during trading, a decline of 68% from the average daily volume of 837,835 shares. The stock had previously […]
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report)’s stock price traded up 5.2% during mid-day trading on Monday . The company traded as high as $16.03 and last traded at $15.70. 267,345 shares changed hands during trading, a decline of 68% from the average session volume of 837,835 shares. The stock had previously closed […]
Wedbush reissued their outperform rating on shares of Day One Biopharmaceuticals (NASDAQ:DAWN – Free Report) in a research report report published on Wednesday morning, RTT News reports. The brokerage currently has a $33.00 target price on the stock. Wedbush also issued estimates for Day One Biopharmaceuticals’ Q3 2025 earnings at ($0.32) EPS and FY2025 earnings […]
Day One Biopharmaceuticals (NASDAQ:DAWN) Price Target Raised to $36.00 at JPMorgan Chase & Co. themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Insider Selling: Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Insider Sells 10,000 Shares of Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.